No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
Established in 1983 and headquartered in Ahmedabad, India, Dishman Carbogen Amcis Limited provides specialized contract research and manufacturing solutions to the worldwide pharmaceutical sector. The company operates through two main business segments: Contract Research and Manufacturing Services (CR&MS), and Marketable Molecules. Beyond its core services, it manufactures and distributes an extensive portfolio of products, including bulk drugs, chemical intermediates, various phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D derivatives, and fine chemicals. Additionally, its offerings encompass personal care products like hand and body washes, sanitizers, and antiseptics, as well as a range of pharmaceutical and cosmetic formulations, including generic and highly potent active pharmaceutical ingredients. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.
imdcal.comNo one on the platform currently holds DCAL.NS.
No tracked institution reports a position in DCAL.NS as of their last filing.
No one on the platform has traded DCAL.NS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Beat consensus in 0 of the last 2 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-05-20 | $4.00 | $1.39 | -65.3% |
| 2026-02-10 | $4.00 | $-0.83 | -120.8% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| DCAL.NSDishman Carbogen Amcis Limited | $163.16 | -2.45% | $25.6B | — |
| AARTIDRUGS.BOAarti Drugs Limited | $426.85 | -0.32% | $39.0B | — |
| AARTIDRUGS.NSAarti Drugs Limited | $426.35 | -0.50% | $38.9B | — |
| INNOVACAP.NSInnova Captab Limited | $1140.10 | -0.62% | $65.2B | — |
| SPARC.BOSun Pharma Advanced Research Company Limited | $188.20 | -4.03% | $60.9B | — |
| SPARC.NSSun Pharma Advanced Research Company Limited | $188.00 | -4.09% | $61.0B | — |
| SUPRIYA.BOSupriya Lifescience Ltd | $874.70 | -2.81% | $70.4B | — |
Source: Financial Modeling Prep · peers by sector/industry